Abstract:Background: Nonsmall-cell lung cancer (NSCLC) is one of the most common malignant tumors, and the current drugs have not achieved ideal therapeutic effects. The abnormal activation of STAT3 and FAK signal transduction in tumor cells is highly correlated with their proliferation and migration ability. Therefore, bioactive compounds that can inhibit STAT3 and FAK activation have the potential to become agents to treat NSCLC. Purpose: This study aims to discover new antitumor compounds from Garcinia xipshuanbannaensis and investigate the molecular mechanism by which they inhibit lung cancer proliferation and metastasis in vivo and in vitro, all of which may lead to obtainment of a potential antitumor agent. Methods: Xipsxanthone H was obtained by various chromatography methods (including silica gel, medium pressure liquid chromatography (MPLC), and preparative high-performance liquid chromatography (HPLC)). 1D and 2D nuclear magnetic resonance (NMR) spectra were used to analyze the structure. Cell viability and wound healing assays were employed to detect changes in the proliferation and migration of cancer cells. Cell cycle and apoptosis were analyzed by flow cytometry. The protein expression of STAT3 and FAK signaling pathways affected by xipsxanthone H was determined by Western blotting. The zebrafish model was used to evaluate the in vivo effects of xipshantone H on tumor proliferation and metastasis. Molecular docking was utilized to explore the interaction between xipsxanthone H and STAT3. Cellular thermal shift assays (CETSAs) were employed to explore the possible target of xipsxanthone H. Results: The novel compound xipsxanthone H was purified and characterized from G. xipshuanbannaensis. Xipsxanthone H exhibited strong anti-proliferation activity in a variety of tumor cell lines. In addition to inducing reactive oxygen species (ROS) production and arresting the cell cycle, mechanistic studies demonstrated that xipsxanthone H suppressed STAT3 and FAK phosphorylation and regulated the downstream protein expression of the STAT3 and FAK signaling pathways. The in vivo studies using the zebrafish model revealed that xipsxanthone H inhibited tumor proliferation, metastasis, and angiogenesis. Conclusions: A new xanthone was obtained from G. xipshuanbannaensis, and this compound had the property of inhibiting tumor proliferation and metastasis by targeting STAT3 and FAK signaling pathways in NSCLC. These findings suggested that xipsxanthone H might be a potential candidate agent for NSCLC treatment.

Tizanidine (hydrochloride) Inhibits A549 Lung Cancer Cell Proliferation and Motility Through Regulating Nischarin.

Molecular mechanism of trifluoperazine induces apoptosis in human A549 lung adenocarcinoma cell lines

SNX-2112 Induces Apoptosis and Inhibits Proliferation, Invasion, and Migration of Non-Small Cell Lung Cancer by Downregulating Epithelial-Mesenchymal Transition via the Wnt/β-Catenin Signaling Pathway

Benzethonium Chloride Suppresses Lung Cancer Tumorigenesis Through Inducing P38-Mediated Cyclin D1 Degradation.

THZ1 Suppresses Human Non-Small-cell Lung Cancer Cells in Vitro Through Interference with Cancer Metabolism

Isotoosendanin exerts anti-tumor effects in NSCLC by enhancing the stability of SHP-2 and inhibiting the JAK/STAT3 pathway

Xanthorrhizol Inhibits Non‐small Cell Carcinoma (A549) Cell Growth and Promotes Apoptosis Through Modulation of PI3K/AKT and NF‐κB Signaling Pathway

Discovery of Tryptanthrin and Its Derivatives and Its Activities against NSCLC In Vitro via Both Apoptosis and Autophagy Pathways

A Natural Xanthone Suppresses Lung Cancer Growth and Metastasis by Targeting STAT3 and FAK Signaling Pathways

Nannocystin Ax, a Natural Elongation Factor 1α Inhibitor from Nannocystis Sp., Suppresses Epithelial-Mesenchymal Transition, Adhesion and Migration in Lung Cancer Cells

Glycyrrhizin suppresses lung adenocarcinoma cell growth through inhibition of thromboxane synthase.

XAV939 inhibits the proliferation and migration of lung adenocarcinoma A549 cells through the WNT pathway

Jatrorrhizine Inhibits Mammary Carcinoma Cells by Targeting TNIK Mediated Wnt/β-catenin Signalling and Epithelial-Mesenchymal Transition (EMT).

Nitroxoline Inhibits Bladder Cancer Progression by Reversing EMT Process and Enhancing Anti-Tumor Immunity

Anthelmintics nitazoxanide protects against experimental pulmonary fibrosis

Inhibition of lung tumor growth by targeting EGFR/VEGFR-Akt/NF-κB pathways with novel theanine derivatives.

Si Jun Zi decoction inhibits the growth of lung cancer by reducing the expression of PD-L1 through TLR4/MyD88/NF-κB pathway

Inhibition of JNK/STAT3/NF-KB pathway-mediated migration and clonal formation of lung adenocarcinoma A549 cells by daphnetin

ACT001 Inhibits the Proliferation of Non‐small Cell Lung Cancer Cells by Upregulating NKTR Expression

Nisin ZP, an Antimicrobial Peptide, Induces Cell Death and Inhibits Non-Small Cell Lung Cancer (NSCLC) Progression in vitro in 2D and 3D Cell Culture

Neuronatin Promotes the Progression of Non-Small Cell Lung Cancer by Activating the NF-κB Signaling